A significant development in the treatment of advanced melanoma has recently emerged: tumor-infiltrating lymphocyte (TIL) ...

The Christie NHS Foundation Trust together with the Cancer Research UK National Biomarker Centre and The University of ...

China: A new meta-analysis published in Annals of Medicine has identified elevated C-reactive protein (CRP) levels as a ...

Like other cancers, melanoma is rising among young adults. It's now the 2nd most common cancer in 15 to 39 year-olds.

Researchers studied the progression-free and overall survival rates of patients with advanced melanoma after cessation of immune checkpoint inhibitor therapy.

A new study led by researchers at Lund University in Sweden reveals that melanoma can, in some cases, be driven by ...

MoleMap take high-resolution photos of customers’ bodies to map, diagnose and monitor the development of lesions – in an ...

Pathologists' examinations of tissue samples from skin cancer tumors improved when they were assisted by an AI tool. The ...

A new study explores a one-and-done radiotherapy for non-melanoma skin cancer – no scalpels, no stitches, just science.

Researchers have discovered that the most aggressive melanomas, the deadliest form of skin cancer, overactivate two key ...

Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for ...

The idea that a prolonged interval between diagnosing and treating uveal melanoma can affect prognosis has been at the centre of an active debate.1–5 This issue focuses on a key question for ...